Keywords: Anti-mycobacterial therapy; Crohn’s disease; Crohn’s strictures; Mycobacterium avium subspecies paratuberculosis (MAP); dysbiosis; fecal microbiota transplantation; gut microbiome; inflammatory bowel disease; profound remission.